3 results
Primary Study ObjectiveTo assess the non-inferiority of the 12-week triptorelin formulation Pamorelin® 11,25 mg administered via subcutaneous (SC) injection as compared to Pamorelin® 11,25 mg administered via registered intramuscular (IM) injection…
This new developed knee prosthesis will be compared to the standard scorpio PS knee prosthesis. In this comparison it will be examined if the changes in design really do improve function and deminish pain. Allso patella tracking and patella tilting…
This new developed knee prosthesis will be compared to the standard scorpio PS knee prosthesis. In this comparison it will be examined ifthe changes in design really do improve function and deminish pain. Allso patella tracking and patella tilting…